# # #

You are now viewing Investors / Hidden / Financials

#

Financials

v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2025
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 22,690,618 $ 17,357,944
Accounts receivable, net of allowance of $359,088 and $355,464 6,320,988 7,527,572
Revenues in excess of billings, net of allowance of $31,662 and $34,496 13,994,651 18,230,619
Other current assets 3,586,732 3,203,468
Total current assets 46,592,989 46,319,603
Revenues in excess of billings, net - long term 881,053 903,766
Property and equipment, net 5,188,592 5,073,372
Right of use assets - operating leases 653,418 809,513
Other assets 6,938 32,331
Goodwill 9,302,524 9,302,524
Total assets 62,625,514 62,441,109
Current liabilities:    
Accounts payable and accrued expenses 9,191,552 8,010,844
Current portion of loans and obligations under finance leases 8,330,243 8,240,061
Current portion of operating lease obligations 401,655 433,242
Unearned revenue 3,735,828 3,029,850
Total current liabilities 21,659,278 19,713,997
Loans and obligations under finance leases; less current maturities 218,170 134,608
Operating lease obligations; less current maturities 224,417 333,374
Total liabilities 22,101,865 20,181,979
Stockholders’ equity:    
Preferred stock, $.01 par value; 500,000 shares authorized;
Common stock, $.01 par value; 18,000,000 shares authorized; 12,733,907 shares issued and 11,794,876 outstanding as of September 30, 2025; 12,700,465 shares issued and 11,761,434 outstanding as of June 30, 2025 127,342 127,008
Additional paid-in-capital 129,636,251 129,529,901
Treasury stock (at cost, 939,031 shares as of September 30, 2025 and June 30, 2025) (3,920,856) (3,920,856)
Accumulated deficit (43,646,368) (41,289,080)
Other comprehensive loss (46,402,374) (46,613,208)
Total NetSol stockholders’ equity 35,793,995 37,833,765
Non-controlling interest 4,729,654 4,425,365
Total stockholders’ equity 40,523,649 42,259,130
Total liabilities and stockholders’ equity $ 62,625,514 $ 62,441,109

Source

PDF HTML
10-Q Filing
ZIP HTML
XBRL
v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Net Revenues:    
Total net revenues $ 15,011,923 $ 14,598,498
Cost of revenues 9,099,933 8,034,386
Gross profit 5,911,990 6,564,112
Operating expenses:    
Selling, general and administrative 7,536,353 6,964,321
Research and development cost 214,343 359,949
Total operating expenses 7,750,696 7,324,270
Income (loss) from operations (1,838,706) (760,158)
Other income and (expenses)    
Interest expense (174,611) (258,219)
Interest income 280,974 769,867
Gain (loss) on foreign currency exchange transactions (286,917) 542,545
Other income 17,670 153,491
Total other income (expenses) (162,884) 1,207,684
Net income before income taxes (2,001,590) 447,526
Income tax provision (215,775) (229,817)
Net income (2,217,365) 217,709
Non-controlling interest (139,923) (146,914)
Net income attributable to NetSol $ (2,357,288) $ 70,795
Net income per share:    
Basic $ (0.20) $ 0.006
Diluted $ (0.20) $ 0.006
Weighted average number of shares outstanding    
Basic 11,767,811 11,429,695
Diluted 11,767,811 11,482,754
License [Member]    
Net Revenues:    
Total net revenues $ 72,225 $ 1,229
Subscription and Support [Member]    
Net Revenues:    
Total net revenues 8,960,555 8,192,471
Service [Member]    
Net Revenues:    
Total net revenues $ 5,979,143 $ 6,404,798

Source

PDF HTML
10-Q Filing
ZIP HTML
XBRL
v3.25.3
Condensed Consolidated Statements of Cash Flows(Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ (2,217,365) $ 217,709
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 324,606 365,997
Provision for bad debts (1,583) 336,506
Gain on sale of assets (16,613)
Stock based compensation 145,400 47,779
Changes in operating assets and liabilities:    
Accounts receivable 1,218,992 6,738,384
Revenues in excess of billing 4,282,495 836,403
Other current assets (323,491) (222,359)
Accounts payable and accrued expenses 1,176,241 10,546
Unearned revenue 714,879 (2,813,220)
Net cash provided by operating activities 5,303,561 5,517,745
Cash flows from investing activities:    
Purchases of property and equipment (485,281) (100,737)
Sales of property and equipment 16,687
Investment in associates 25,396
Purchase of subsidiary shares (7,895)
Net cash used in investing activities (443,198) (108,632)
Cash flows from financing activities:    
Proceeds from the exercise of stock options and warrants 21,500
Proceeds from exercise of subsidiary options 64,147
Proceeds from bank loans 242,421 250,000
Payments on finance lease obligations and loans - net (115,350) (118,311)
Net cash provided by financing activities 191,218 153,189
Effect of exchange rate changes 281,093 (163,511)
Net increase (decrease) in cash and cash equivalents 5,332,674 5,398,791
Cash and cash equivalents at beginning of the period 17,357,944 19,127,165
Cash and cash equivalents at end of period 22,690,618 24,525,956
Cash paid during the period for:    
Interest 165,954 285,362
Taxes $ 100,011 $ 264,030

Source

PDF HTML
10-Q Filing
ZIP HTML
XBRL